CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.250
+0.120 (2.91%)
Dec 16, 2025, 4:00 PM EST - Market closed
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $720.1 million as of December 17, 2025. Its market cap has increased by 767.59% in one year.
Market Cap
720.10M
Enterprise Value
582.07M
1-Year Change
767.59%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $720.10M, an increase of 9,631.09%. That is a compound annual growth rate of 56.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 720.10M | 793.42% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.06B |
| Johnson & Johnson | 516.00B |
| AbbVie | 401.99B |
| UnitedHealth Group | 308.98B |
| AstraZeneca | 282.48B |
| Novartis AG | 258.61B |
| Merck & Co. | 248.85B |
| Abbott Laboratories | 223.39B |